Soung, Jennifer http://orcid.org/0009-0009-5586-0677
Laquer, Vivian
Merola, Joseph F.
Moore, Angela
Elmaraghy, Hany
Hu, Chaoran
Piruzeli, Maria Lucia Buziqui
Pierce, Evangeline
Garcia Gil, Esther
Jarell, Abel D.
Clinical trials referenced in this document:
Documents that mention this clinical trial
The Impact of Lebrikizumab on Vaccine-Induced Immune Responses: Results from a Phase 3 Study in Adult Patients with Moderate-to-Severe Atopic Dermatitis
https://doi.org/10.1007/s13555-024-01217-w
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 19 April 2024
Accepted: 18 June 2024
First Online: 15 July 2024
Declarations
:
: Hany Elmaraghty, Chaoran Hu, Maria Lucia Buziqui Piruzeli, and Evangeline Pierce, are all employees and shareholders of Eli Lilly and Company. Esther Garcia Gil is an employee and shareholder of Almirall. Jennifer Soung has received honoraria or research funds Amgen, Eli Lilly, Abbvie, Pfizer, National Psoriasis Foundation, LEO, Regeneron, Sanofi, Arcutis, Dermavant, Novartis. Joseph Merola declares that he has acted as a consultant for AbbVie, Biogen, Celgene, Dermavant, Eli Lilly, Janssen, Leo Pharma, Novartis, Pfizer and UCB. Angela Moore has received honoraria or research funds from Arcutis, Abbvie, Aclaris, Almirall, Bayer, Bristol Meyers Squibb, Cara Therapeutics, Galderma, Incyte, Janssen, Eli Lilly and Company, Pfizer, Rapt, Regeneron, Sanofi, and Therapeutics. Vivian Laquer conducts research for Abbvie, Acelyrin, Acrotech, Amgen, Argenx, Arcutis, Aslan, Biofrontera, Bristol Meyers Squibb, Cara, Dermavant, Eli Lilly and Company, Galderma, Horizon Therapeutics, Incyte, Janssen, Leo, Novartis, Padagis, Pfizer, Q32, Rapt, Sun, UCB and Ventyx. Abell Jarell has received honoraria and/or research grants from AbbVie, Almirall, Alumis, Apogee Therapeutics, Arcutis Biotherapeutics, Asana Biosciences, BMS, Castle Biosciences, Concert Pharmaceuticals, Dermavant Sciences, Dermira, Eli Lilly and Company, Foamix Pharmaceuticals, Galderma, Incyte Corporation, Janssen Biotech, Leo Pharma, Novartis, Pfizer, Takeda Pharmaceuticals, UCB, and Vivex Biomedical.
: The trials were conducted in accordance with ethical principles of the Declaration of Helsinki and Good Clinical Practice guidelines, and the research protocols were approved by each center’s institutional review board or ethics committee. All patients provided written informed consent.